Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/303% above fair value
$100.72−1.60 (-1.56%)
Close on Nov 18, 2026Market cap $128.83BP/E 24.7Yield 2.82%
Medtronic operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Medtronic's operating income for the twelve months ending Jul 31, 2026 was $6.79B, up 10.9% year over year. For fiscal 2026 it was $6.47B, up 8.6% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $6.64B in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $6.47B | +8.6% |
| FY2025 | Apr 25, 2025 | $5.96B | +15.8% |
| FY2024 | Apr 26, 2024 | $5.14B | -6.2% |
| FY2023 | Apr 28, 2023 | $5.49B | -4.6% |
| FY2022 | Apr 29, 2022 | $5.75B | +28.3% |
| FY2021 | Apr 30, 2021 | $4.48B | -6.4% |
| FY2020 | Apr 24, 2020 | $4.79B | -23.6% |
| FY2019 | Apr 26, 2019 | $6.27B | -5.6% |
| FY2018 | Apr 27, 2018 | $6.64B | +23.4% |
| FY2017 | Apr 28, 2017 | $5.38B | +0.4% |
| FY2016 | Apr 29, 2016 | $5.36B | +42.4% |
| FY2015 | Apr 24, 2015 | $3.77B | -1.2% |
| FY2014 | Apr 25, 2014 | $3.81B | -13.4% |
| FY2013 | Apr 26, 2013 | $4.40B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $1.76B | +22.1% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $1.87B | +30.4% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $1.46B | -11.1% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $1.69B | +5.7% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $1.45B | +13.1% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $1.44B | +36.4% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $1.65B | +11.0% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $1.60B | +19.0% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $1.28B | +0.8% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $1.05B | -32.7% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $1.48B | +6.5% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $1.34B | -4.6% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $1.27B | +12.7% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $1.57B | -6.3% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $1.39B | -16.1% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $1.40B | -10.2% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $1.13B | +31.0% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $1.67B | +4.1% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $1.66B | +29.9% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $1.56B | +68.1% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $859.00M | +27.6% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.61B | +407.9% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $1.28B | -22.1% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $930.00M | -31.2% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $673.00M | -54.7% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $316.00M | -83.8% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $1.64B | +6.3% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $1.35B | -12.5% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $1.49B | +20.1% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $1.95B | +0.9% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $1.54B | +7.4% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $1.54B | -18.5% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $1.24B | -10.6% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $1.93B | +14.5% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $1.44B | +25.2% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $1.89B | +36.8% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $1.38B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $1.68B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $1.15B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $1.39B | – |
See a number that looks wrong?